Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine medication used for the short-term management of anxiety disorders, insomnia, and seizures. It enhances GABAergic neurotransmission, leading to sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant effects.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus and other seizure types
* Premedication for medical/surgical procedures
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally every 6 to 8 hours as needed. Maximum daily dose typically 10 mg.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg administered intravenously or intramuscularly. May repeat after 10 to 15 minutes if seizure persists. Maximum dose 8 mg in 24 hours for initial treatment.
* **Premedication:** 1 mg to 4 mg orally or intravenously 1 to 2 hours before procedure.
Dosing should be individualized based on patient response and tolerability.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be based on specific indication, weight, and clinical response.
* **Status Epilepticus:** 0.05 mg/kg to 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. Can be repeated every 5 to 10 minutes.
Use in pediatric patients should be cautious due to potential for respiratory depression and limited long-term safety data.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment, but monitor for accumulation.
* **Elderly:** Initiate at lower doses (e.g., 0.5 mg orally twice daily) and titrate slowly due to increased sensitivity and risk of side effects like confusion and falls.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* History of paradoxical reactions to benzodiazepines.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness.
Less Common: Confusion, depression, blurred vision, nausea, amnesia.
Serious: Respiratory depression, paradoxical excitation, dependence, withdrawal symptoms.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Additive CNS depression, increased risk of sedation, respiratory depression, coma, and death.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic Acid:** May increase lorazepam levels and risk of toxicity.
## Monitoring
* For sedation and cognitive impairment, especially in the elderly.
* Respiratory rate and depth, particularly with IV administration or in patients with respiratory compromise.
* Signs of dependence and withdrawal upon discontinuation.
* Effectiveness for the specific indication.
## Clinical Pearls
* Lorazepam has an intermediate half-life compared to other benzodiazepines.
* Intramuscular absorption can be slow and erratic; IV route is preferred for rapid effect, but carries a higher risk of adverse events.
* Avoid abrupt discontinuation due to risk of withdrawal seizures and symptoms. Tapering is recommended.
* Due to its potential for abuse and dependence, lorazepam should generally be used for short durations.
***
*Please verify the current prescribing information for the most up-to-date dosing, indications, and safety information.*
